Uğur Şahin (English Wikipedia)

Petra Spielberg (2019), "Ugur Sahin: Mit individualisierten Therapien gegen den Krebs.", Deutsches Ärzteblatt (in German), no. 116, retrieved 26 October 2020

aerztezeitung.de (Global: low place; English: low place)

"Erfolgreiche Suche nach Tumormarkern", Ärzte Zeitung (in German), Springer Medizin, 13 October 2005, retrieved 26 October 2020

bdi.de (Global: low place; English: low place)

Uni Mainz hat neues Tumor-Zentrum. (in German), Berufsverband Deutscher Internisten, 22 June 2011, archived from the original on 25 February 2021, retrieved 26 October 2020

birmingham.ac.uk (Global: low place; English: 7,843^rd place)

Ugur Sahin, Managing Director (Science and Research) of Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz – Tron, University of Birmingham, archived from the original on 3 May 2017, retrieved 26 October 2020

bloomberg.com (Global: 99^th place; English: 77^th place)

"Bloomberg Billionaires Index: Ugur Sahin". Bloomberg L.P. Retrieved 21 June 2021.
"Ugur Sahin, Profile and Biography", Bloomberg, retrieved 26 October 2020

bmbf.de (Global: low place; English: low place)

Präzisionsschlag gegen den Krebs (in German), Bundesministerium für Bildung und Forschung (BMBF). Sieg gegen Krebs nicht unmöglich., 14 February 2019, archived from the original on 28 November 2020, retrieved 26 October 2020

bpb.de (Global: 1,752^nd place; English: 5,699^th place)

Anne Seibring (11 December 2020). "Editorial". Bundeszentrale für politische Bildung. Retrieved 31 January 2021.

bundespraesident.de (Global: 5,030^th place; English: low place)

"Bundespräsident ehrt Özlem Türeci und Uğur Şahin mit Verdienstorden" [Federal President honors Özlem Türeci and Uğur Şahin with Order of Merit]. bundespraesident.de (in German). Retrieved 30 June 2021.

businessinsider.com (Global: 140^th place; English: 115^th place)

Döpfner, Mathias (23 March 2021). "INTERVIEW: BioNTech founders Özlem Türeci and Ugur Sahin on developing the BioNTech-Pfizer COVID-19 vaccine, the future of fighting cancer, and whether people can live to 200". Business Insider.

businessinsider.de (Global: 7,631^st place; English: low place)

Rudnick, Hendrikje (11 November 2020). "Von Gastarbeiter-Kindern zu Milliardären: Biontech-Chef Ugur Sahin und seine Frau Özlem Türeci gehören zu den 100 reichsten Deutschen". Business Insider (in German). Retrieved 15 November 2020.

cancerresearch.org (Global: low place; English: low place)

"William B. Coley Award". Cancer Research Institute. Retrieved 16 November 2021.

ccc-netzwerk.de (Global: low place; English: low place)

CCC-Netzwerk der Deutschen Krebshilfe – Mitglieder – Mainz (in German), Stiftung Deutsche Krebshilfe, retrieved 26 October 2020

ci-3.de (Global: low place; English: low place)

The Cluster for Individualized Immune Intervention (Ci3), retrieved 26 October 2020

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

"A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma", ClinicalTrials, U.S. National Library of Medicine, retrieved 26 October 2020
"Advanced Search", ClinicalTrials, U.S. National Library of Medicine, retrieved 25 November 2020

cnn.com (Global: 28^th place; English: 26^th place)

Paul R. La Monica (16 October 2020), "Pfizer May File for Early COVID-19 Vaccine Use – but Not Until After the Election", CNN Business, Cable News Network, A Warner Media Company, retrieved 26 October 2020

desy.de (Global: low place; English: low place)

"DESY News: Karl Heinz Beckurts Prize awarded at DESY". www.desy.de. Retrieved 16 November 2021.

deutschland.de (Global: low place; English: low place)

Johannes Göbel (26 March 2015). "Erfolgreiches "Mainzer Modell"" [Successful Mainz Model]. Deutschland-Portal (in German). Fazit Communication, German Federal Foreign Office. Retrieved 26 October 2020. The awards are to be given to them by President Frank-Walter Steinmeier at Bellevue Palace, the presidential residence on 19 March.

dgfi.org (Global: low place; English: low place)

"Koehler-Preis", Dgfi (in German), Deutsche Gesellschaft für Immunologie, 20 June 2018, retrieved 26 October 2020

dgho.de (Global: low place; English: low place)

Preisträger Vincenz-Czerny-Preis und deren Arbeiten (in German), Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, retrieved 26 October 2020

dkfz.de (Global: low place; English: low place)

hi-tron.dkfz.de

"Sahin Lab - mRNA Cancer Immunotherapies Division - HI-TRON". hi-tron.dkfz.de. Retrieved 23 March 2025.

dkfz.de

Helmholtz-Institut für Translationale Onkologie Mainz (in German), Deutsches Krebsforschungszentrum, retrieved 26 October 2020

dktk.dkfz.de

Viermal Deutscher Krebspreis für DKTK Wissenschaftler (in German), Deutsches Konsortium für Translationale Krebsforschung (DKTK) – Deutsches Krebsforschungszentrum, 28 February 2019, retrieved 26 October 2020

doi.org (Global: 2^nd place; English: 2^nd place)

O Türeci; U Sahin; H Schulze-Bergkamen; et al. (1 September 2019). "A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study". Annals of Oncology. 30 (9): 1487–1495. doi:10.1093/ANNONC/MDZ199. ISSN 0923-7534. PMC 6771222. PMID 31240302. Wikidata Q93031588.
Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Uğur Şahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci (1 December 2008). "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development". Clinical Cancer Research. 14 (23): 7624–7634. doi:10.1158/1078-0432.CCR-08-1547. ISSN 1078-0432. PMID 19047087. S2CID 5543394. Wikidata Q45401730.
Silke Holtkamp; Sebastian Kreiter; Abderraouf Selmi; Petra Simon; Michael Koslowski; Christoph Huber; Ozlem Türeci; Uğur Şahin (29 August 2006). "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells". Blood. 108 (13): 4009–4017. doi:10.1182/BLOOD-2006-04-015024. ISSN 0006-4971. PMID 16940422. Wikidata Q54585198.
Sebastian Kreiter; Abderraouf Selmi; Mustafa Diken; et al. (1 January 2008). "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals". Journal of Immunology. 180 (1): 309–318. doi:10.4049/JIMMUNOL.180.1.309. ISSN 0022-1767. PMID 18097032. S2CID 83698413. Wikidata Q57221515.
A N Kuhn; M Diken; S Kreiter; et al. (22 April 2010). "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo". Gene Therapy. 17 (8): 961–971. doi:10.1038/GT.2010.52. ISSN 0969-7128. PMID 20410931. S2CID 647837. Wikidata Q45858586.
Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
Beck, J. D.; Reidenbach, D.; Salomon, N.; Sahin, U.; Vormehr, M.; Kranz, L. M. (2021), "mRNA therapeutics in cancer immunotherapy", Molecular Cancer, 20 (1): 69, doi:10.1186/s12943-021-01348-0, PMC 8047518, PMID 33858437
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Flemming, A. (2021), "mRNA vaccine shows promise in autoimmunity", Nature Reviews. Immunology, 21 (2): 72, doi:10.1038/s41577-021-00504-3, PMC 7802056, PMID 33437044
Wardell, C. M.; Levings, M. K. (2021), "mRNA vaccines take on immune tolerance", Nature Biotechnology, 39 (4): 419–421, doi:10.1038/s41587-021-00880-0, PMID 33785909, S2CID 232431542
Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; et al. (18 December 2018). "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening". Molecular Therapy. 27 (4): 824–836. doi:10.1016/J.YMTHE.2018.12.011. ISSN 1525-0016. PMC 6453560. PMID 30638957. Wikidata Q91028225.
Sahin, U.; et al. (2021), "BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans", Nature, 595 (7868): 572–577, Bibcode:2021Natur.595..572S, doi:10.1038/s41586-021-03653-6, PMID 34044428, S2CID 235232604
Vogel, A. B.; et al. (2021), "BNT162b vaccines protect rhesus macaques from SARS-CoV-2", Nature, 592 (7853): 283–289, Bibcode:2021Natur.592..283V, doi:10.1038/s41586-021-03275-y, PMID 33524990, S2CID 231756922
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.
Brady Huggett; Kathryn Paisner (1 December 2019). "Top 20 translational researchers of 2018". Nature Biotechnology. 37 (12): 1401–1402. doi:10.1038/S41587-019-0323-8. ISSN 1087-0156. PMID 31796919. S2CID 208613402. Wikidata Q91657804.

dw.com (Global: 204^th place; English: 353^rd place)

Hessler, Uwe; Wrede, Insa. "BioNTech vaccine inventors receive Germany's Knight Commander's Cross | DW | 19 March 2021". DW.COM.
"BioNTech founders win top German medicine award | DW | 21.09.2021". Deutsche Welle.

embo.org (Global: low place; English: low place)

"EMBO announces 64 newly elected members – Press releases – EMBO". 8 June 2021. Retrieved 30 June 2021.

emdgroup.com (Global: low place; English: low place)

"HoF - Hall of Fame (Laureates)". emdgroup.com. Retrieved 30 June 2021.

eurekalert.org (Global: 3,538^th place; English: 3,083^rd place)

"UvA honorary doctorates for vaccine developers Ugur Sahin and Özlem Türeci". EurekAlert!. Retrieved 15 May 2022.

express.de (Global: 2,956^th place; English: low place)

Bastian Ebel (11 November 2020), Stolz an Kölner Schule: Irrer Lebensweg: Ex-Abiturient wird in Corona-Zeit zum Weltstar [Pride at a Cologne School: Crazy Life Path: Former Student Becomes World Star in Corona Times] (in German), archived from the original on 17 November 2020, retrieved 20 November 2020

faz.net (Global: 240^th place; English: 1,443^rd place)

"Experte für Immuntherapie: Sieg gegen Krebs nicht unmöglich.", Frankfurter Allgemeine Zeitung (in German), 14 February 2019, ISSN 0174-4909, retrieved 26 October 2020
Kopplin, Ilka; Schleidt, Daniel (16 March 2020), "Mainzer Unternehmen: Wie Biontech gegen Corona kämpft.", Frankfurter Allgemeine Zeitung (in German), retrieved 26 October 2020

finanzen.net (Global: 9,273^rd place; English: low place)

"BioNTech-Aktie", finanzen.net (in German), retrieved 26 October 2020

focus.de (Global: 460^th place; English: 2,405^th place)

Petra Apfel (9 September 2015), "Größte Hoffnung seit Jahrzehnten: Individuelle Krebsimpfung tötet Tumore.", Focus Online (in German), retrieved 26 October 2020

forschung-und-lehre.de (Global: low place; English: low place)

"Impfstoff-Entwickler von Biontech erhalten Zukunftspreis". Forschung & Lehre (in German). 17 November 2021. Retrieved 17 November 2021.

fortune.com (Global: 433^rd place; English: 284^th place)

"This Obscure Biotech May Have a Game-Changing Cancer Med On Its Hands". Fortune. Retrieved 30 June 2021.

fpa.es (Global: 8,139^th place; English: low place)

Princess of Asturias Award 2021

freitag.de (Global: 6,097^th place; English: low place)

Rossmann, Ernst Dieter; Samsami, Behrang (2 December 2020). "Gemeinsam denken" [Thinking together]. Der Freitag. Archived from the original on 2 December 2020. Retrieved 30 January 2021.

ft.com (Global: 210^th place; English: 157^th place)

Joe Miller (20 March 2020), "Ugur Sahin: The Immunologist Racing To Find a Vaccine", Financial Times, retrieved 26 October 2020
Miller, Joe; Cookson, Clive (16 December 2020). "FT People of the Year: BioNTech's Ugur Sahin and Ozlem Tureci". Financial Times. Retrieved 17 December 2020.

go-bio.de (Global: low place; English: low place)

GO-Bio Erfolge (in German), Bundesministerium für Bildung und Forschung (BMBF), retrieved 26 October 2020

handelsblatt.com (Global: 1,065^th place; English: 3,933^rd place)

Siegfried Hofmann, Christian Wermke (23 April 2020), "Ugur Sahin und Özlem Türeci: Dieses Medizinerpaar entwickelt einen Covid-19-Impfstoff.", Handelsblatt (in German), retrieved 26 October 2020

handelsregisterbekanntmachungen.de (Global: low place; English: low place)

"Öffentliche Bekanntmachung RegisSTAR". handelsregisterbekanntmachungen.de (in German). Archived from the original on 4 November 2021. Retrieved 4 November 2021.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Sahin, U.; et al. (2021), "BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans", Nature, 595 (7868): 572–577, Bibcode:2021Natur.595..572S, doi:10.1038/s41586-021-03653-6, PMID 34044428, S2CID 235232604
Vogel, A. B.; et al. (2021), "BNT162b vaccines protect rhesus macaques from SARS-CoV-2", Nature, 592 (7853): 283–289, Bibcode:2021Natur.592..283V, doi:10.1038/s41586-021-03275-y, PMID 33524990, S2CID 231756922
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.

heise.de (Global: 766^th place; English: 3,515^th place)

Tobias Stolzenberg (2018), "Zwei gegen den Krebs", Technology Review (in German), no. 5, Hannover: Heise Verlag, retrieved 26 October 2020
Tobias Stolzenberg (8 October 2018), "Zwei gegen den Krebs", Heise Online (in German), retrieved 26 October 2020
heise online (19 November 2020), Biontech/Pfizer-Corona-Impfstoff: 95 Prozent Wirksamkeit nach Phase-3-Auswertung (in German), retrieved 24 November 2020
"Corona-Impfung erklärt: So funktioniert der programmierbare BioNTech-Impfstoff". c't Magazin (in German). 23 February 2021. Retrieved 30 June 2021.

hmw-emissionshaus.ag (Global: low place; English: low place)

Balzter, Sebastian (21 August 2016). "Das Traumpaar der Biotech-Branche" [The Dream Couple of the Biotech Industry] (PDF). Frankfurter Allgemeine Sonntagszeitung (in German). p. 27. Retrieved 26 October 2020 – via hmw-emissionshaus.ag.

hurriyet.com.tr (Global: 239^th place; English: 831^st place)

Külahçı, Ahmet (18 November 2020). "'Der Retter kommt' (Kurtarıcı geliyor)". Hürriyet. Archived from the original on 29 November 2020. Retrieved 29 January 2021.

idw-online.de (Global: 5,704^th place; English: low place)

nachrichten.idw-online.de

Paul Ehrlich and Ludwig Darmstaedter Prize

idw-online.de

"Özlem Türeci und Uğur Şahin mit dem Ehrenring der Universitätsmedizin Mainz gewürdigt" [Özlem Türeci and Uğur Şahin honored with the Ring of Honor of Mainz University Medicine]. idw-online.de (in German). Retrieved 15 May 2022.

iscoms.com (Global: low place; English: low place)

"Prof. Ugur Sahin, MD PhD", ISCOMS, International Student Congress of (Bio)medical Sciences, archived from the original on 9 November 2020, retrieved 26 October 2020

jeantet.ch (Global: low place; English: low place)

"Uğur ŞAHIN, Özlem TÜRECI and Katalin KARIKÓ | Jeantet". 29 November 2021. Archived from the original on 1 July 2022. Retrieved 15 May 2022.

mainz.de (Global: low place; English: low place)

"Ehrenbürger:innenwürde (Aufzeichnung)". mainz.de (in German). Retrieved 15 May 2022.

medpagetoday.com (Global: 9,274^th place; English: 5,856^th place)

Antibody Shines in Advanced Gastric Cancer, 5 June 2016, retrieved 26 October 2020

mustafaprize.org (Global: low place; English: low place)

The 2019 Mustafa Prize Laureates, archived from the original on 10 November 2020, retrieved 26 October 2020

n-tv.de (Global: 1,071^st place; English: 5,827^th place)

Wolfram Weimer (13 October 2020), "Der Impfstoff naht", n-tv (in German), retrieved 26 October 2020

nachhaltigkeitspreis.de (Global: low place; English: low place)

"Deutscher Nachhaltigkeitspreis: Startseite". Deutscher Nachhaltigkeitspreis (in German). Retrieved 17 December 2020.

nature.com (Global: 234^th place; English: 397^th place)

Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
"Table 1 Top 20 translational researchers in 2015". Nature Biotechnology. ISSN 1546-1696.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

O Türeci; U Sahin; H Schulze-Bergkamen; et al. (1 September 2019). "A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study". Annals of Oncology. 30 (9): 1487–1495. doi:10.1093/ANNONC/MDZ199. ISSN 0923-7534. PMC 6771222. PMID 31240302. Wikidata Q93031588.
Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Uğur Şahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci (1 December 2008). "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development". Clinical Cancer Research. 14 (23): 7624–7634. doi:10.1158/1078-0432.CCR-08-1547. ISSN 1078-0432. PMID 19047087. S2CID 5543394. Wikidata Q45401730.
Stenner-Liewen F; Luo G; Uğur Şahin; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M (1 March 2000). "Definition of tumor-associated antigens in hepatocellular carcinoma". Cancer Epidemiology. 9 (3): 285–290. ISSN 1055-9965. PMID 10750667. Wikidata Q30854839.
Silke Holtkamp; Sebastian Kreiter; Abderraouf Selmi; Petra Simon; Michael Koslowski; Christoph Huber; Ozlem Türeci; Uğur Şahin (29 August 2006). "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells". Blood. 108 (13): 4009–4017. doi:10.1182/BLOOD-2006-04-015024. ISSN 0006-4971. PMID 16940422. Wikidata Q54585198.
Sebastian Kreiter; Abderraouf Selmi; Mustafa Diken; et al. (1 January 2008). "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals". Journal of Immunology. 180 (1): 309–318. doi:10.4049/JIMMUNOL.180.1.309. ISSN 0022-1767. PMID 18097032. S2CID 83698413. Wikidata Q57221515.
A N Kuhn; M Diken; S Kreiter; et al. (22 April 2010). "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo". Gene Therapy. 17 (8): 961–971. doi:10.1038/GT.2010.52. ISSN 0969-7128. PMID 20410931. S2CID 647837. Wikidata Q45858586.
Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
Beck, J. D.; Reidenbach, D.; Salomon, N.; Sahin, U.; Vormehr, M.; Kranz, L. M. (2021), "mRNA therapeutics in cancer immunotherapy", Molecular Cancer, 20 (1): 69, doi:10.1186/s12943-021-01348-0, PMC 8047518, PMID 33858437
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Flemming, A. (2021), "mRNA vaccine shows promise in autoimmunity", Nature Reviews. Immunology, 21 (2): 72, doi:10.1038/s41577-021-00504-3, PMC 7802056, PMID 33437044
Wardell, C. M.; Levings, M. K. (2021), "mRNA vaccines take on immune tolerance", Nature Biotechnology, 39 (4): 419–421, doi:10.1038/s41587-021-00880-0, PMID 33785909, S2CID 232431542
Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; et al. (18 December 2018). "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening". Molecular Therapy. 27 (4): 824–836. doi:10.1016/J.YMTHE.2018.12.011. ISSN 1525-0016. PMC 6453560. PMID 30638957. Wikidata Q91028225.
Sahin, U.; et al. (2021), "BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans", Nature, 595 (7868): 572–577, Bibcode:2021Natur.595..572S, doi:10.1038/s41586-021-03653-6, PMID 34044428, S2CID 235232604
Vogel, A. B.; et al. (2021), "BNT162b vaccines protect rhesus macaques from SARS-CoV-2", Nature, 592 (7853): 283–289, Bibcode:2021Natur.592..283V, doi:10.1038/s41586-021-03275-y, PMID 33524990, S2CID 231756922
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.
Brady Huggett; Kathryn Paisner (1 December 2019). "Top 20 translational researchers of 2018". Nature Biotechnology. 37 (12): 1401–1402. doi:10.1038/S41587-019-0323-8. ISSN 1087-0156. PMID 31796919. S2CID 208613402. Wikidata Q91657804.

ncbi.nlm.nih.gov

O Türeci; U Sahin; H Schulze-Bergkamen; et al. (1 September 2019). "A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study". Annals of Oncology. 30 (9): 1487–1495. doi:10.1093/ANNONC/MDZ199. ISSN 0923-7534. PMC 6771222. PMID 31240302. Wikidata Q93031588.
Beck, J. D.; Reidenbach, D.; Salomon, N.; Sahin, U.; Vormehr, M.; Kranz, L. M. (2021), "mRNA therapeutics in cancer immunotherapy", Molecular Cancer, 20 (1): 69, doi:10.1186/s12943-021-01348-0, PMC 8047518, PMID 33858437
Flemming, A. (2021), "mRNA vaccine shows promise in autoimmunity", Nature Reviews. Immunology, 21 (2): 72, doi:10.1038/s41577-021-00504-3, PMC 7802056, PMID 33437044
Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; et al. (18 December 2018). "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening". Molecular Therapy. 27 (4): 824–836. doi:10.1016/J.YMTHE.2018.12.011. ISSN 1525-0016. PMC 6453560. PMID 30638957. Wikidata Q91028225.
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)

novonordiskfonden.dk (Global: low place; English: low place)

"Four scientists receive the Novo Nordisk Prize for their combined contributions to COVID-19 mRNA vaccine". Novo Nordisk Fonden. Retrieved 15 May 2022.

nytimes.com (Global: 7^th place; English: 7^th place)

Gelles, David (10 November 2020). "The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19". The New York Times. Retrieved 17 November 2020.

orcid.org (Global: low place; English: low place)

"Ugur Sahin – Biography", ORCID, retrieved 26 October 2020

orden-pourlemerite.de (Global: low place; English: low place)

"Şahin". ORDEN POUR LE MÉRITE (in German). Retrieved 18 December 2023.

politico.eu (Global: 1,347^th place; English: 909^th place)

"Özlem Türeci". POLITICO. 7 December 2020. Retrieved 11 July 2021.

prnewswire.com (Global: 406^th place; English: 258^th place)

Novo. "Recipients of the Novo Nordisk Prize played major role in the research and development of the COVID-19 mRNA vaccine". www.prnewswire.com (Press release). Retrieved 5 April 2024.

rlp.de (Global: 1,472^nd place; English: 3,759^th place)

Ministerpräsidentin Malu Dreyer sagt Mainzer Impfstoffentwickler BioNTech Unterstützung zu. (in German), Staatskanzlei Rheinland-Pfalz, 15 May 2020, archived from the original on 27 October 2020, retrieved 26 October 2020

rtl.de (Global: 1,285^th place; English: 6,808^th place)

"Corona-Impfstoff könnte Biontech-Gründer Ugur Sahin weltberühmt machen". RTL (in German). 21 October 2020. Retrieved 26 October 2020.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Uğur Şahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci (1 December 2008). "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development". Clinical Cancer Research. 14 (23): 7624–7634. doi:10.1158/1078-0432.CCR-08-1547. ISSN 1078-0432. PMID 19047087. S2CID 5543394. Wikidata Q45401730.
Sebastian Kreiter; Abderraouf Selmi; Mustafa Diken; et al. (1 January 2008). "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals". Journal of Immunology. 180 (1): 309–318. doi:10.4049/JIMMUNOL.180.1.309. ISSN 0022-1767. PMID 18097032. S2CID 83698413. Wikidata Q57221515.
A N Kuhn; M Diken; S Kreiter; et al. (22 April 2010). "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo". Gene Therapy. 17 (8): 961–971. doi:10.1038/GT.2010.52. ISSN 0969-7128. PMID 20410931. S2CID 647837. Wikidata Q45858586.
Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Wardell, C. M.; Levings, M. K. (2021), "mRNA vaccines take on immune tolerance", Nature Biotechnology, 39 (4): 419–421, doi:10.1038/s41587-021-00880-0, PMID 33785909, S2CID 232431542
Sahin, U.; et al. (2021), "BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans", Nature, 595 (7868): 572–577, Bibcode:2021Natur.595..572S, doi:10.1038/s41586-021-03653-6, PMID 34044428, S2CID 235232604
Vogel, A. B.; et al. (2021), "BNT162b vaccines protect rhesus macaques from SARS-CoV-2", Nature, 592 (7853): 283–289, Bibcode:2021Natur.592..283V, doi:10.1038/s41586-021-03275-y, PMID 33524990, S2CID 231756922
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.
Brady Huggett; Kathryn Paisner (1 December 2019). "Top 20 translational researchers of 2018". Nature Biotechnology. 37 (12): 1401–1402. doi:10.1038/S41587-019-0323-8. ISSN 1087-0156. PMID 31796919. S2CID 208613402. Wikidata Q91657804.

sfb1399.de (Global: low place; English: low place)

"Prof. Dr. med. Ugur Sahin", SFB 1399: Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer, Department of Translational Genomics, University of Cologne, retrieved 26 October 2020

sitcancer.org (Global: low place; English: low place)

"SITC Medal of Honor - Society for Immunotherapy of Cancer (SITC)". www.sitcancer.org. Retrieved 16 November 2021.

spiegel.de (Global: 66^th place; English: 350^th place)

Anton Rainer (10 November 2020). "Biontech-Impfstoff: Wie Google eine Impf-Forscherin zur "Ehefrau" macht". Der Spiegel (in German). Retrieved 11 July 2021.

spitzencluster.de (Global: low place; English: low place)

Cluster für Individualisierte ImmunIntervention (Ci3) – BMBF Spitzencluster (in German), Bundesministerium für Bildung und Forschung (BMBF), archived from the original on 20 March 2021, retrieved 26 October 2020

swr.de (Global: 1,755^th place; English: 8,499^th place)

"BioNTech-Gründer mit Landesverdienstorden geehrt" [BioNTech founder honored with State Order of Merit]. SWR Aktuell (in German). 26 January 2022. Archived from the original on 20 May 2022. Retrieved 15 May 2022.
"Biontech-Gründer sind Mainzer Ehrenbürger" [Biontech founders are honorary citizens of Mainz]. SWR Aktuell (in German). 10 March 2022. Archived from the original on 5 April 2022. Retrieved 15 May 2022.

tagesspiegel.de (Global: 458^th place; English: 1,945^th place)

Akyün, Hatice (26 April 2020). "Über zwei Wissenschaftler, die nicht nur Hoffnung gegen das Virus machen". Der Tagesspiegel Online (in German). Tagesspiegel. Retrieved 17 September 2021. Beide sind Kinder türkischer Einwanderer, deutsche Staatsbürger und weltweit angesehene Wissenschaftler. [Both are children of Turkish immigrants, German citizens, and internationally respected scientists]
Hatice Akyün (26 April 2020). ""Wir sind Impfstoff": Über zwei Wissenschaftler, die nicht nur Hoffnung gegen das Virus machen" ["We are vaccine": Two Scientists give hope, and not just against the virus]. Der Tagesspiegel (in German). Retrieved 26 October 2020.

theeuropean.de (Global: low place; English: low place)

Stefan Groß-Lobkowicz (23 October 2020), "Corona-Impfstoff: Für 2020 haben wir bis zu 100 Millionen Dosen geplant.", The European (in German), Weimer Media Group, retrieved 26 October 2020

theguardian.com (Global: 12^th place; English: 11^th place)

Philip Oltermann (10 November 2020). "Uğur Şahin and Özlem Türeci: German 'dream team' behind vaccine". The Guardian. Archived from the original on 17 January 2021. Retrieved 6 February 2021. The comments hinted at the scientific rigour, unrelenting work ethic and appetite for entrepreneurship that has seen Sahin and Türeci's company outpace more well-established competitors in the race for a Covid-19 vaccine – and made the couple the first Germans with Turkish roots to enter their country's rich list this autumn, at number 93.

theophano.eu (Global: low place; English: low place)

"Theophano Foundation – Prize 2021". theophano.eu. Retrieved 30 June 2021.
"The Empress Theophano Prize Honours the Contribution of Science to Humankind".

transkript.de (Global: low place; English: low place)

"Astellas kauft Ganymed", Transkript (in German), 28 October 2016, archived from the original on 11 July 2020, retrieved 26 October 2020

tron-mainz.de (Global: low place; English: low place)

Über TRON (in German), TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, archived from the original on 20 March 2021, retrieved 26 October 2020
Management (in German), TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, archived from the original on 19 November 2020, retrieved 26 October 2020

uni-heidelberg.de (Global: 1,681^st place; English: 2,023^rd place)

klinikum.uni-heidelberg.de

"Prof. Ugur Sahin, M.D.: Universitätsklinikum Heidelberg". www.klinikum.uni-heidelberg.de. Retrieved 23 March 2025.

uni-mainz.de (Global: 9,571^st place; English: low place)

fzi.uni-mainz.de

Prof. Dr. Ugur Sahin, Mitglied des FZI (PDF), Forschungszentrum für Immuntherapie (FZI) der Johannes Gutenberg-Universität Mainz, retrieved 26 October 2020

uni-mainz.de

Neues Spitzenforschungsinstitut in Mainz: TRON – Translationale Onkologie. Bindeglied zwischen Universität, Universitätsmedizin und Wirtschaft., Ministerium für Wissenschaft, Weiterbildung und Kultur des Landes Rheinland-Pfalz, 18 February 2010, archived from the original on 18 November 2020, retrieved 26 October 2020

uni-marburg.de (Global: 7,035^th place; English: 9,229^th place)

"Ehrendoktorwürde für Özlem Türeci und Uğur Şahin". Philipps-Universität Marburg (in German). Retrieved 15 May 2022.

unimedizin-mainz.de (Global: low place; English: low place)

Geschäftsführung (in German), Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz), retrieved 26 October 2020
Renée Dillinger-Reiter (1 March 2017), Personalisierte Immuntherapie gegen Krebs (in German), Universitätsmedizin Mainz, retrieved 26 October 2020
Renée Dillinger-Reiter (28 February 2019), Professor Ugur Sahin erhält den Deutschen Krebspreis 2019 (in German), Universitätsmedizin Mainz, retrieved 26 October 2020

uspto.gov (Global: 1,459^th place; English: 991^st place)

patft.uspto.gov

"Advanced Search", Patent Full-Text and Image Database, U.S. Patent and Trademark Office, archived from the original on 28 November 2020, retrieved 25 November 2020

warrenalpert.org (Global: low place; English: low place)

"Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 15 May 2022.

web.archive.org (Global: 1^st place; English: 1^st place)

"Öffentliche Bekanntmachung RegisSTAR". handelsregisterbekanntmachungen.de (in German). Archived from the original on 4 November 2021. Retrieved 4 November 2021.
Philip Oltermann (10 November 2020). "Uğur Şahin and Özlem Türeci: German 'dream team' behind vaccine". The Guardian. Archived from the original on 17 January 2021. Retrieved 6 February 2021. The comments hinted at the scientific rigour, unrelenting work ethic and appetite for entrepreneurship that has seen Sahin and Türeci's company outpace more well-established competitors in the race for a Covid-19 vaccine – and made the couple the first Germans with Turkish roots to enter their country's rich list this autumn, at number 93.
Külahçı, Ahmet (18 November 2020). "'Der Retter kommt' (Kurtarıcı geliyor)". Hürriyet. Archived from the original on 29 November 2020. Retrieved 29 January 2021.
Rossmann, Ernst Dieter; Samsami, Behrang (2 December 2020). "Gemeinsam denken" [Thinking together]. Der Freitag. Archived from the original on 2 December 2020. Retrieved 30 January 2021.
Bastian Ebel (11 November 2020), Stolz an Kölner Schule: Irrer Lebensweg: Ex-Abiturient wird in Corona-Zeit zum Weltstar [Pride at a Cologne School: Crazy Life Path: Former Student Becomes World Star in Corona Times] (in German), archived from the original on 17 November 2020, retrieved 20 November 2020
Uni Mainz hat neues Tumor-Zentrum. (in German), Berufsverband Deutscher Internisten, 22 June 2011, archived from the original on 25 February 2021, retrieved 26 October 2020
Präzisionsschlag gegen den Krebs (in German), Bundesministerium für Bildung und Forschung (BMBF). Sieg gegen Krebs nicht unmöglich., 14 February 2019, archived from the original on 28 November 2020, retrieved 26 October 2020
Über TRON (in German), TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, archived from the original on 20 March 2021, retrieved 26 October 2020
Management (in German), TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, archived from the original on 19 November 2020, retrieved 26 October 2020
Neues Spitzenforschungsinstitut in Mainz: TRON – Translationale Onkologie. Bindeglied zwischen Universität, Universitätsmedizin und Wirtschaft., Ministerium für Wissenschaft, Weiterbildung und Kultur des Landes Rheinland-Pfalz, 18 February 2010, archived from the original on 18 November 2020, retrieved 26 October 2020
"Astellas kauft Ganymed", Transkript (in German), 28 October 2016, archived from the original on 11 July 2020, retrieved 26 October 2020
Ministerpräsidentin Malu Dreyer sagt Mainzer Impfstoffentwickler BioNTech Unterstützung zu. (in German), Staatskanzlei Rheinland-Pfalz, 15 May 2020, archived from the original on 27 October 2020, retrieved 26 October 2020
Cluster für Individualisierte ImmunIntervention (Ci3) – BMBF Spitzencluster (in German), Bundesministerium für Bildung und Forschung (BMBF), archived from the original on 20 March 2021, retrieved 26 October 2020
"Advanced Search", Patent Full-Text and Image Database, U.S. Patent and Trademark Office, archived from the original on 28 November 2020, retrieved 25 November 2020
Ugur Sahin, Managing Director (Science and Research) of Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz – Tron, University of Birmingham, archived from the original on 3 May 2017, retrieved 26 October 2020
"Prof. Ugur Sahin, MD PhD", ISCOMS, International Student Congress of (Bio)medical Sciences, archived from the original on 9 November 2020, retrieved 26 October 2020
Prof. Ugur Sahin Receives Prestigious European Research Council (ERC) Advanced Grant for Personalized Cancer Vaccines (in German), Mainzer Wissenschaftsallianz, 19 April 2018, archived from the original on 8 December 2020, retrieved 26 October 2020
The 2019 Mustafa Prize Laureates, archived from the original on 10 November 2020, retrieved 26 October 2020
"Uğur ŞAHIN, Özlem TÜRECI and Katalin KARIKÓ | Jeantet". 29 November 2021. Archived from the original on 1 July 2022. Retrieved 15 May 2022.
"BioNTech-Gründer mit Landesverdienstorden geehrt" [BioNTech founder honored with State Order of Merit]. SWR Aktuell (in German). 26 January 2022. Archived from the original on 20 May 2022. Retrieved 15 May 2022.
"Biontech-Gründer sind Mainzer Ehrenbürger" [Biontech founders are honorary citizens of Mainz]. SWR Aktuell (in German). 10 March 2022. Archived from the original on 5 April 2022. Retrieved 15 May 2022.

welt.de (Global: 201^st place; English: 1,038^th place)

"Neues Helmholtz-Institut", Die Welt (in German), 14 February 2019, retrieved 26 October 2020

wikidata.org (Global: 43^rd place; English: 161^st place)

O Türeci; U Sahin; H Schulze-Bergkamen; et al. (1 September 2019). "A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study". Annals of Oncology. 30 (9): 1487–1495. doi:10.1093/ANNONC/MDZ199. ISSN 0923-7534. PMC 6771222. PMID 31240302. Wikidata Q93031588.
Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Uğur Şahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci (1 December 2008). "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development". Clinical Cancer Research. 14 (23): 7624–7634. doi:10.1158/1078-0432.CCR-08-1547. ISSN 1078-0432. PMID 19047087. S2CID 5543394. Wikidata Q45401730.
Stenner-Liewen F; Luo G; Uğur Şahin; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M (1 March 2000). "Definition of tumor-associated antigens in hepatocellular carcinoma". Cancer Epidemiology. 9 (3): 285–290. ISSN 1055-9965. PMID 10750667. Wikidata Q30854839.
Silke Holtkamp; Sebastian Kreiter; Abderraouf Selmi; Petra Simon; Michael Koslowski; Christoph Huber; Ozlem Türeci; Uğur Şahin (29 August 2006). "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells". Blood. 108 (13): 4009–4017. doi:10.1182/BLOOD-2006-04-015024. ISSN 0006-4971. PMID 16940422. Wikidata Q54585198.
Sebastian Kreiter; Abderraouf Selmi; Mustafa Diken; et al. (1 January 2008). "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals". Journal of Immunology. 180 (1): 309–318. doi:10.4049/JIMMUNOL.180.1.309. ISSN 0022-1767. PMID 18097032. S2CID 83698413. Wikidata Q57221515.
A N Kuhn; M Diken; S Kreiter; et al. (22 April 2010). "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo". Gene Therapy. 17 (8): 961–971. doi:10.1038/GT.2010.52. ISSN 0969-7128. PMID 20410931. S2CID 647837. Wikidata Q45858586.
Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; et al. (18 December 2018). "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening". Molecular Therapy. 27 (4): 824–836. doi:10.1016/J.YMTHE.2018.12.011. ISSN 1525-0016. PMC 6453560. PMID 30638957. Wikidata Q91028225.
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.
Brady Huggett; Kathryn Paisner (1 December 2019). "Top 20 translational researchers of 2018". Nature Biotechnology. 37 (12): 1401–1402. doi:10.1038/S41587-019-0323-8. ISSN 1087-0156. PMID 31796919. S2CID 208613402. Wikidata Q91657804.

wissenschaftsallianz-mainz.de (Global: low place; English: low place)

Prof. Ugur Sahin Receives Prestigious European Research Council (ERC) Advanced Grant for Personalized Cancer Vaccines (in German), Mainzer Wissenschaftsallianz, 19 April 2018, archived from the original on 8 December 2020, retrieved 26 October 2020

wiwo.de (Global: 3,921^st place; English: low place)

Salz, Jürgen (8 September 2020), "Biontech-Chef Ugur Sahin: 'Wir wollen keine Abkürzung gehen.'", WirtschaftsWoche (in German), retrieved 26 October 2020
Jürgen Salz, Silke Wettach (9 September 2020), "Nach zähen Verhandlungen: EU kauft Millionen Dosen Impfstoff bei Biontech und Pfizer ein.", WirtschaftsWoche (in German), retrieved 26 October 2020

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

"Experte für Immuntherapie: Sieg gegen Krebs nicht unmöglich.", Frankfurter Allgemeine Zeitung (in German), 14 February 2019, ISSN 0174-4909, retrieved 26 October 2020
O Türeci; U Sahin; H Schulze-Bergkamen; et al. (1 September 2019). "A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study". Annals of Oncology. 30 (9): 1487–1495. doi:10.1093/ANNONC/MDZ199. ISSN 0923-7534. PMC 6771222. PMID 31240302. Wikidata Q93031588.
Bojan Pancevski, Jared S. Hopkins (22 October 2020), "How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race. Small German Biotech Was a Niche Player in Futuristic Cancer Treatments—Then Pivoted When COVID-19 Broke Out in China.", The Wall Street Journal, Dow Jones & Company, ISSN 0099-9660, retrieved 26 October 2020
Katharina Reinhard; Benjamin Rengstl; Petra Oehm; et al. (2 January 2020). "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors". Science. 367 (6476): 446–453. Bibcode:2020Sci...367..446R. doi:10.1126/SCIENCE.AAY5967. ISSN 0036-8075. PMID 31896660. S2CID 209671821. Wikidata Q92379967.
Uğur Şahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci (1 December 2008). "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development". Clinical Cancer Research. 14 (23): 7624–7634. doi:10.1158/1078-0432.CCR-08-1547. ISSN 1078-0432. PMID 19047087. S2CID 5543394. Wikidata Q45401730.
Stenner-Liewen F; Luo G; Uğur Şahin; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M (1 March 2000). "Definition of tumor-associated antigens in hepatocellular carcinoma". Cancer Epidemiology. 9 (3): 285–290. ISSN 1055-9965. PMID 10750667. Wikidata Q30854839.
Silke Holtkamp; Sebastian Kreiter; Abderraouf Selmi; Petra Simon; Michael Koslowski; Christoph Huber; Ozlem Türeci; Uğur Şahin (29 August 2006). "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells". Blood. 108 (13): 4009–4017. doi:10.1182/BLOOD-2006-04-015024. ISSN 0006-4971. PMID 16940422. Wikidata Q54585198.
Sebastian Kreiter; Abderraouf Selmi; Mustafa Diken; et al. (1 January 2008). "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals". Journal of Immunology. 180 (1): 309–318. doi:10.4049/JIMMUNOL.180.1.309. ISSN 0022-1767. PMID 18097032. S2CID 83698413. Wikidata Q57221515.
A N Kuhn; M Diken; S Kreiter; et al. (22 April 2010). "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo". Gene Therapy. 17 (8): 961–971. doi:10.1038/GT.2010.52. ISSN 0969-7128. PMID 20410931. S2CID 647837. Wikidata Q45858586.
Ugur Sahin; Katalin Karikó; Özlem Türeci (19 September 2014). "mRNA-based therapeutics--developing a new class of drugs" (PDF). Nature Reviews Drug Discovery. 13 (10): 759–780. doi:10.1038/NRD4278. ISSN 1474-1776. PMID 25233993. S2CID 27454546. Wikidata Q38252360.
Christina Krienke; Laura Kolb; Elif Diken; et al. (7 January 2021). "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis". Science. 371 (6525): 145–153. Bibcode:2021Sci...371..145K. doi:10.1126/SCIENCE.AAY3638. ISSN 0036-8075. PMID 33414215. S2CID 231138578. Wikidata Q104766936.
Alexandra G Orlandini von Niessen; Marco A Poleganov; Corina Rechner; et al. (18 December 2018). "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening". Molecular Therapy. 27 (4): 824–836. doi:10.1016/J.YMTHE.2018.12.011. ISSN 1525-0016. PMC 6453560. PMID 30638957. Wikidata Q91028225.
Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; et al. (10 December 2020). "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine". The New England Journal of Medicine. doi:10.1056/NEJMOA2034577. hdl:10757/655958. ISSN 0028-4793. PMC 7745181. PMID 33301246. S2CID 228087117. Wikidata Q104265015.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Philip Ball (18 December 2020). "The lightning-fast quest for COVID vaccines - and what it means for other diseases". Nature. Bibcode:2021Natur.589...16B. doi:10.1038/D41586-020-03626-1. ISSN 1476-4687. PMID 33340018. S2CID 229324351. Wikidata Q104503055.
"Table 1 Top 20 translational researchers in 2015". Nature Biotechnology. ISSN 1546-1696.
Brady Huggett; Kathryn Paisner (1 December 2019). "Top 20 translational researchers of 2018". Nature Biotechnology. 37 (12): 1401–1402. doi:10.1038/S41587-019-0323-8. ISSN 1087-0156. PMID 31796919. S2CID 208613402. Wikidata Q91657804.

wsj.com (Global: 79^th place; English: 65^th place)

Bojan Pancevski, Jared S. Hopkins (22 October 2020), "How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race. Small German Biotech Was a Niche Player in Futuristic Cancer Treatments—Then Pivoted When COVID-19 Broke Out in China.", The Wall Street Journal, Dow Jones & Company, ISSN 0099-9660, retrieved 26 October 2020

youtube.com (Global: 9^th place; English: 13^th place)

"Entwicklung innovativer Impfstoffe gegen Krebserkrankungen" [Development of innovative vaccines against cancer]. YouTube (in German). 5 March 2012. 10:47. Retrieved 26 October 2020.

Uğur Şahin (English Wikipedia)

aerzteblatt.de (Global: 3,043rd place; English: low place)

aerztezeitung.de (Global: low place; English: low place)

bdi.de (Global: low place; English: low place)

birmingham.ac.uk (Global: low place; English: 7,843rd place)

bloomberg.com (Global: 99th place; English: 77th place)

bmbf.de (Global: low place; English: low place)

bpb.de (Global: 1,752nd place; English: 5,699th place)

bundespraesident.de (Global: 5,030th place; English: low place)

businessinsider.com (Global: 140th place; English: 115th place)

businessinsider.de (Global: 7,631st place; English: low place)

cancerresearch.org (Global: low place; English: low place)

ccc-netzwerk.de (Global: low place; English: low place)

ci-3.de (Global: low place; English: low place)

clinicaltrials.gov (Global: 5,225th place; English: 4,062nd place)

cnn.com (Global: 28th place; English: 26th place)

desy.de (Global: low place; English: low place)

deutschland.de (Global: low place; English: low place)

dgfi.org (Global: low place; English: low place)

dgho.de (Global: low place; English: low place)

dkfz.de (Global: low place; English: low place)

hi-tron.dkfz.de

dkfz.de

dktk.dkfz.de

doi.org (Global: 2nd place; English: 2nd place)

dw.com (Global: 204th place; English: 353rd place)

embo.org (Global: low place; English: low place)

emdgroup.com (Global: low place; English: low place)

eurekalert.org (Global: 3,538th place; English: 3,083rd place)

express.de (Global: 2,956th place; English: low place)

faz.net (Global: 240th place; English: 1,443rd place)

finanzen.net (Global: 9,273rd place; English: low place)

focus.de (Global: 460th place; English: 2,405th place)

forschung-und-lehre.de (Global: low place; English: low place)

fortune.com (Global: 433rd place; English: 284th place)

fpa.es (Global: 8,139th place; English: low place)

freitag.de (Global: 6,097th place; English: low place)

ft.com (Global: 210th place; English: 157th place)

go-bio.de (Global: low place; English: low place)

handelsblatt.com (Global: 1,065th place; English: 3,933rd place)

handelsregisterbekanntmachungen.de (Global: low place; English: low place)

handle.net (Global: 102nd place; English: 76th place)

hdl.handle.net

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

heise.de (Global: 766th place; English: 3,515th place)

hmw-emissionshaus.ag (Global: low place; English: low place)

hurriyet.com.tr (Global: 239th place; English: 831st place)

idw-online.de (Global: 5,704th place; English: low place)

nachrichten.idw-online.de

idw-online.de

iscoms.com (Global: low place; English: low place)

jeantet.ch (Global: low place; English: low place)

mainz.de (Global: low place; English: low place)

medpagetoday.com (Global: 9,274th place; English: 5,856th place)

mustafaprize.org (Global: low place; English: low place)

n-tv.de (Global: 1,071st place; English: 5,827th place)

nachhaltigkeitspreis.de (Global: low place; English: low place)

nature.com (Global: 234th place; English: 397th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

novonordiskfonden.dk (Global: low place; English: low place)

nytimes.com (Global: 7th place; English: 7th place)

orcid.org (Global: low place; English: low place)

orden-pourlemerite.de (Global: low place; English: low place)

politico.eu (Global: 1,347th place; English: 909th place)

prnewswire.com (Global: 406th place; English: 258th place)

rlp.de (Global: 1,472nd place; English: 3,759th place)

rtl.de (Global: 1,285th place; English: 6,808th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

sfb1399.de (Global: low place; English: low place)

sitcancer.org (Global: low place; English: low place)

spiegel.de (Global: 66th place; English: 350th place)

spitzencluster.de (Global: low place; English: low place)

swr.de (Global: 1,755th place; English: 8,499th place)

tagesspiegel.de (Global: 458th place; English: 1,945th place)

theeuropean.de (Global: low place; English: low place)

theguardian.com (Global: 12th place; English: 11th place)

aerzteblatt.de (Global: 3,043^rd place; English: low place)

birmingham.ac.uk (Global: low place; English: 7,843^rd place)

bloomberg.com (Global: 99^th place; English: 77^th place)

bpb.de (Global: 1,752^nd place; English: 5,699^th place)

bundespraesident.de (Global: 5,030^th place; English: low place)

businessinsider.com (Global: 140^th place; English: 115^th place)

businessinsider.de (Global: 7,631^st place; English: low place)

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

cnn.com (Global: 28^th place; English: 26^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

dw.com (Global: 204^th place; English: 353^rd place)

eurekalert.org (Global: 3,538^th place; English: 3,083^rd place)

express.de (Global: 2,956^th place; English: low place)

faz.net (Global: 240^th place; English: 1,443^rd place)

finanzen.net (Global: 9,273^rd place; English: low place)

focus.de (Global: 460^th place; English: 2,405^th place)

fortune.com (Global: 433^rd place; English: 284^th place)

fpa.es (Global: 8,139^th place; English: low place)

freitag.de (Global: 6,097^th place; English: low place)

ft.com (Global: 210^th place; English: 157^th place)

handelsblatt.com (Global: 1,065^th place; English: 3,933^rd place)

handle.net (Global: 102^nd place; English: 76^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

heise.de (Global: 766^th place; English: 3,515^th place)

hurriyet.com.tr (Global: 239^th place; English: 831^st place)

idw-online.de (Global: 5,704^th place; English: low place)

medpagetoday.com (Global: 9,274^th place; English: 5,856^th place)

n-tv.de (Global: 1,071^st place; English: 5,827^th place)

nature.com (Global: 234^th place; English: 397^th place)

nih.gov (Global: 4^th place; English: 4^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

politico.eu (Global: 1,347^th place; English: 909^th place)

prnewswire.com (Global: 406^th place; English: 258^th place)

rlp.de (Global: 1,472^nd place; English: 3,759^th place)

rtl.de (Global: 1,285^th place; English: 6,808^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

spiegel.de (Global: 66^th place; English: 350^th place)

swr.de (Global: 1,755^th place; English: 8,499^th place)

tagesspiegel.de (Global: 458^th place; English: 1,945^th place)

theguardian.com (Global: 12^th place; English: 11^th place)

uni-heidelberg.de (Global: 1,681^st place; English: 2,023^rd place)

uni-mainz.de (Global: 9,571^st place; English: low place)

uni-marburg.de (Global: 7,035^th place; English: 9,229^th place)

uspto.gov (Global: 1,459^th place; English: 991^st place)

web.archive.org (Global: 1^st place; English: 1^st place)

welt.de (Global: 201^st place; English: 1,038^th place)

wikidata.org (Global: 43^rd place; English: 161^st place)

wiwo.de (Global: 3,921^st place; English: low place)

worldcat.org (Global: 5^th place; English: 5^th place)

wsj.com (Global: 79^th place; English: 65^th place)

youtube.com (Global: 9^th place; English: 13^th place)